Dithiocarbamates for the treatment of atherosclerosis and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/325 (2006.01) A61K 31/145 (2006.01) A61K 31/185 (2006.01) A61K 31/198 (2006.01) A61K 31/40 (2006.01) A61K 45/06 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2147881

Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplastry restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.

Des dithocarboxylates, et en particulier des dithiocarbamates, bloquent l'expression induite d'une molécule d'adhésion à la surface de cellules endothéliales VCAM-1, et se révèlent donc utiles dans le traitement de maladies cardiovasculaires, y compris l'athérosclérose, la resténose post-angioplastie, les maladies des artères coronaires et l'angine de poitrine, ainsi que des maladies inflammatoires non cardiovasculaires faisant l'objet d'une médiation par VCAM-1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dithiocarbamates for the treatment of atherosclerosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dithiocarbamates for the treatment of atherosclerosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dithiocarbamates for the treatment of atherosclerosis and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1471845

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.